All In Biotech

Free tool

FAERS Monitor: Gemcitabine Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209604 or its brand name (Gemcitabine Hydrochloride, Gemcitabine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

14,000

Serious

13,603

97% of reports

Hospitalization

6,282

Death reported

2,613

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,385
  • myelosuppression1,153
  • malignant neoplasm progression846
  • thrombocytopenia766
  • anaemia679
  • neutropenia668
  • pyrexia667
  • nausea627
  • vomiting534
  • platelet count decreased505
  • diarrhoea498
  • death490
  • neoplasm progression478
  • febrile neutropenia463
  • fatigue449

Reports by year received

View as table
YearReports
200414
200514
200631
20071
20084
20095
201089
2011486
2012629
2013482
2014489
2015457
2016534
2017597
2018768
20191,148
20201,112
20211,018
20221,028
20231,189
20241,542
20251,394
2026969

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,159 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal1,15349.646.953,249
neoplasm progressionSignal47820.919.28,943
malignant neoplasm progressionSignal84612.511.78,914
febrile neutropeniaSignal46310.69.63,979
thrombocytopeniaSignal76610.49.76,455
neutropeniaSignal6687.46.93,705
platelet count decreasedSignal5057.16.62,665
anaemiaSignal6795.45.02,420
pyrexiaSignal6672.92.7840
off label useSignal1,3852.42.31,151
vomiting5341.71.6159
nausea6271.21.120
diarrhoea4981.21.111
fatigue4490.90.89
death4900.90.813

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.